Evidence map›Paper›PMID 35997471›Full record

ArticleEmerging infectious diseases2022

Invasive Meningococcal X Disease during the COVID-19 Pandemic, Brazil.

Lucila O Fukasawa, Bernadete L Liphaus, Maria Gisele Gonçalves, Fabio T Higa, Carlos H Camargo, Telma R M P Carvalhanas, Ana Paula S Lemos

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Hybrid response to SARS-CoV-2 andHuman vaccines & immunotherapeutics · 2024
    Article
  2. Genomic characterization of invasive meningococcal X isolates from Brazil, 1992-2022.International microbiology : the official journal of the Spanish Society for Microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Lucila O Fukasawa
Bernadete L Liphaus
Maria Gisele Gonçalves
Fabio T Higa
Carlos H Camargo
Telma R M P Carvalhanas
Ana Paula S Lemos
Institute of Health Research, Epidemiological Surveillance and Training · SNHôpital Raymond-Poincaré · FR

Funding

Wellcome Trust
6 · The paper itself

Abstract

Invasive meningococcal disease persists as a fulminant disorder worldwide. Although cases caused by Neisseria meningitidis serogroup X (MenX) occur infrequently, outbreaks have been reported in countries in Africa in recent decades. We report 2 cases of MenX invasive meningococcal disease in São Paulo, Brazil, in 2021 and 2022, during the COVID-19 pandemic.

Indexed as

COVID-19Meningitis, MeningococcalMeningococcal InfectionsMeningococcal VaccinesNeisseria meningitidisBrazilHumansPandemicsMeningococcal VaccinesBrazilCOVID-19invasive meningococcal diseasemeningitis/encephalitisMeningococcal X diseaseMenXNeisseira meningitidis serogroup XSARs-CoV-2

Identifiers

PMID35997471
PMCPMC9423920
OpenAlexW4292615305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.